A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Clinical trial NCT06933472 · RECRUITING

Trial details

NCT number: NCT06933472
Sponsor: Alebund Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia Chronic Kidney Disease, Receiving Dialysis ESRD (End-Stage Renal Disease)Dialysis

Start date: 2025-06-13
Primary completion: 2026-06-20
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.